REPOSITORY FOR HUMAN IMMUNODEFICIENCY (HIV) SPECIMENS

此次收购的目的是为NIAID提供一种 来自队列研究、疫苗试验和 其他由艾滋病项目赞助的研究。 从这些研究中产生的样本的中央储存库 以确保：1)样品存储在 可行的条件；2)标本可供将来取回 随着新的假设和新的分析方法的产生而进行的研究 可用；3)政府控制建立 今后利用这些珍贵标本的优先事项 学习。目前，NIAID标本库维护 大约一百万个生物样本。这是意料之中的 将收集大约一百万个生物样本 在接下来的五年里。拟议的合同应规定 标本、数据、冰柜和材料的及时运输 从现有设施到拟建设施。

The purpose of this acquisition is to provide NIAID with a repository for specimens from cohort studies, vaccine trials and other studies that are sponsored by the AIDS Program. A centralized repository for specimens generated from these studies is needed in order to ensure: 1) that specimens are stored in viable condition; 2) that specimens are retrievable for future studies as new hypotheses are generated and new assays become available; 3) that the Government has control over establishing priorities for utilization of these valuable specimens for future studies. At present, the NIAID specimen repository maintains approximately one million biologic specimens. It is anticipated that approximately one million biologic specimens will be collected over the next five years. The proposed contract shall provide for the timely transport of specimens, data, freezers and materials from the existing facilities to the proposed facilities.